Skip to main content

UK Biofuel Shop Licenses Integrated Genomics' Software for Microbe/Ethanol Research

NEW YORK (GenomeWeb News) — Integrated Genomics has licensed its ERGO genomic-analysis software to TMO Renewables, a UK-based biofuels developer, the companies said today.
TMO plans to use the software for gene annotation, metabolic reconstruction, enzyme data mining, and comparative genomics projects that could help develop microbial methods for the production of cellulosic ethanol.
Steve Martin, TMO's associate director of R&D, said the company thinks it has developed organisms that can produce bioethanol "quickly and efficiently from a wide diversity of sustainable cellulosic feedstocks."
Martin said the ERGO software will help the company further develop these thermophilic microbe strains "to develop the next generation of green biofuels."
IG said the ERGO platform holds over 1,180 genomes "at various stages of completion," along with a collection of networked cellular pathways.

Filed under

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.